Home
/ MEDINET
/ Competitors

MEDINET Competitors and Similar CompaniesClear all

MEDINET's competitors and similar companies include OncoTherapy Science, Iksuda Therapeutics, Bexion Pharmaceuticals and Numab.

	MEDINET MEDINET is a contract development and manufacturing organization (CDMO) focused on the cancer immuno-cell therapy.	OncoTherapy Science OncoTherapy Science is a company engaged in research and development of cancer therapeutics.	Iksuda Therapeutics Iksuda is a biotechnology company that focuses on developing antibody-based therapies for the treatment of cancer.	Bexion Pharmaceuticals Bexion Pharmaceuticals is a company committed to the discovery, clinical development, and acquisition of oncology treatments.	Numab Numab Therapeutics is an oncology-focused biopharmaceutical company.
Founding Date	Founding Date 1995	Founding Date 2001	Founding Date 2007	Founding Date 2006	Founding Date 2011
Type	Type Public	Type Public	Type Private	Type Private	Type Private
Tags	Tags Healthcare biotech contractor drug development oncology therapy	Tags Healthcare biotech drug development oncology therapy	Tags Healthcare biotech drug development oncology therapy	Tags Healthcare biotech drug development oncology therapy	Tags Healthcare biotech drug development oncology therapy
Locations	Locations Ota City, JP HQ Shinagawa City, JP	Locations Kawasaki, JP HQ	Locations Newcastle upon Tyne, GB HQ Newton, US	Locations Covington, US HQ	Locations Wädenswil, CH HQ
Employees	Employees 92	Employees 54	Employees 43	Employees 274% increase	Employees 681% decrease
Valuation ($)	Valuation ($) 70.2 m	Valuation ($) 56.9 m	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) ¥810.3m (FY, 2025)	Revenue (est.) ¥808.5m (FY, 2026)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods ¥625.3m (FY, 2025)	Cost of goods ¥794.6m (FY, 2026)	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit ¥185m (FY, 2025)	Gross profit ¥14m (FY, 2026)	Gross profit N/A	Gross profit N/A	Gross profit N/A
Net income	Net income (¥1.4b) (FY, 2025)	Net income (¥910.6m) (FY, 2026)	Net income N/A	Net income N/A	Net income N/A
Funding
Latest funding round	Latest funding round N/A	Latest funding round N/A	Latest funding round $ 47m (almost 5 years ago)	Latest funding round $ 16.6m (about 7 years ago)	Latest funding round $ 110m (about 5 years ago)
Total funding raised	Total funding raised $ 4.3m	Total funding raised N/A	Total funding raised $ 47m	Total funding raised $ 16.6m	Total funding raised $ 132.3m